215 related articles for article (PubMed ID: 18269585)
21. Translocations involving the immunoglobulin heavy chain gene locus predict better survival in gastric diffuse large B-cell lymphoma.
Nakamura S; Ye H; Bacon CM; Goatly A; Liu H; Kerr L; Banham AH; Streubel B; Yao T; Tsuneyoshi M; Savio A; Takeshita M; Dartigues P; Ruskoné-Fourmestraux A; Matsumoto T; Iida M; Du MQ
Clin Cancer Res; 2008 May; 14(10):3002-10. PubMed ID: 18445693
[TBL] [Abstract][Full Text] [Related]
22. Diffuse large B-cell lymphoma initially manifesting in the bone marrow.
Kajiura D; Yamashita Y; Mori N
Am J Clin Pathol; 2007 May; 127(5):762-9. PubMed ID: 17439835
[TBL] [Abstract][Full Text] [Related]
23. Bone marrow biopsy in non-Hodgkin lymphoma: a morphological study.
Kumar S; Rau AR; Naik R; Kini H; Mathai AM; Pai MR; Khadilkar UN
Indian J Pathol Microbiol; 2009; 52(3):332-8. PubMed ID: 19679954
[TBL] [Abstract][Full Text] [Related]
24. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.
Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST
Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110
[TBL] [Abstract][Full Text] [Related]
25. Diffuse large B-cell lymphoma in the young in Japan: a study by the Osaka Lymphoma Study Group.
Yamauchi A; Fujita S; Ikeda J; Nakamichi I; Fukuhara S; Hino M; Kanakura Y; Ogawa H; Sugiyama H; Kanamaru A; Aozasa K
Am J Hematol; 2007 Oct; 82(10):893-7. PubMed ID: 17573693
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathologic significance of immunophenotypic profiles related to germinal center and activation B-cell differentiation in diffuse large B-cell lymphoma from Chinese patients.
Liu YH; Xu FP; Zhuang HG; Lai KC; Xie D; Luo DL; Li L; Luo XL; Xu J; Zhang MH; Zhang F; Li HM
Hum Pathol; 2008 Jun; 39(6):875-84. PubMed ID: 18440593
[TBL] [Abstract][Full Text] [Related]
27. Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcome.
Chigrinova E; Mian M; Scandurra M; Greiner TC; Chan WC; Vose JM; Inghirami G; Chiappella A; Baldini L; Ponzoni M; Ferreri AJ; Franceschetti S; Gaidano G; Tucci A; Facchetti F; Lazure T; Lambotte O; Montes-Moreno S; Piris MA; Nomdedeu JF; Uccella S; Rancoita PM; Kwee I; Zucca E; Bertoni F
Hematol Oncol; 2011 Mar; 29(1):38-41. PubMed ID: 20635329
[TBL] [Abstract][Full Text] [Related]
28. Diffuse large B-cell lymphoma: clinical characterization and prognosis of Waldeyer ring versus lymph node presentation.
Qi SN; Li YX; Wang H; Wang WH; Jin J; Song YW; Wang SL; Liu YP; Zhou LQ; Yu ZH
Cancer; 2009 Nov; 115(21):4980-9. PubMed ID: 19634158
[TBL] [Abstract][Full Text] [Related]
29. [Prognostic value of a focal bone marrow lesion in diffuse large B-cell lymphosarcoma].
Magomedova AU; Kremenetskaia AM; Vorob'ev IA; Kravchenko SK; Kaplanskaia IB; Samoĭlova RS; Gemdzhian EG; Vorob'ev AI
Ter Arkh; 2004; 76(7):60-3. PubMed ID: 15379130
[TBL] [Abstract][Full Text] [Related]
30. Aberrations of the MYC gene in unselected cases of diffuse large B-cell lymphoma are rare and unpredictable by morphological or immunohistochemical assessment.
Obermann EC; Csato M; Dirnhofer S; Tzankov A
J Clin Pathol; 2009 Aug; 62(8):754-6. PubMed ID: 19638549
[TBL] [Abstract][Full Text] [Related]
31. Bone marrow trephine biopsy involvement by lymphoma: pattern of involvement and concordance with flow cytometry, in 10 years from a single institution.
Cabezas-Quintario MA; Gomez P; Yuste-Del Pozo V; Valencia-Mesa AL; Sosa G; Ricard P; Hijas-Gómez AI; Pinedo F; Arguelles M
Clin Transl Oncol; 2016 May; 18(5):537-40. PubMed ID: 26311078
[TBL] [Abstract][Full Text] [Related]
32. Correlation of serum IL-6, IL-8 and IL-10 levels with clinicopathological features and prognosis in patients with diffuse large B-cell lymphoma.
Nacinović-Duletić A; Stifter S; Dvornik S; Skunca Z; Jonjić N
Int J Lab Hematol; 2008 Jun; 30(3):230-9. PubMed ID: 18479302
[TBL] [Abstract][Full Text] [Related]
33. Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.
Fu K; Weisenburger DD; Choi WW; Perry KD; Smith LM; Shi X; Hans CP; Greiner TC; Bierman PJ; Bociek RG; Armitage JO; Chan WC; Vose JM
J Clin Oncol; 2008 Oct; 26(28):4587-94. PubMed ID: 18662967
[TBL] [Abstract][Full Text] [Related]
34. [Expression of Cdc7 and mcm2 as a marker for proliferation and prognosis in diffuse large B cell lymphoma].
Hou Y; Wang HQ; Fu K; Zhang HL; Qian ZZ; Qiu LH; Li W; Zhou SY; Li LF; Hao XS
Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):911-5. PubMed ID: 22340100
[TBL] [Abstract][Full Text] [Related]
35. Routine use of ancillary investigations in staging diffuse large B-cell lymphoma improves the International Prognostic Index (IPI).
Talaulikar D; Shadbolt B; Dahlstrom JE; McDonald A
J Hematol Oncol; 2009 Nov; 2():49. PubMed ID: 19930611
[TBL] [Abstract][Full Text] [Related]
36. Primary bone lymphoma: a new and detailed characterization of 28 patients in a single-institution study.
Maruyama D; Watanabe T; Beppu Y; Kobayashi Y; Kim SW; Tanimoto K; Makimoto A; Kagami Y; Terauchi T; Matsuno Y; Tobinai K
Jpn J Clin Oncol; 2007 Mar; 37(3):216-23. PubMed ID: 17472971
[TBL] [Abstract][Full Text] [Related]
37. [Flow fluorimetry in differential diagnosis of diffuse large B-cell lymphoma].
Vorob'ev IA; Gorgidze LA; Gretsov EM; Korneva EP; Kharazishvili DV; Khudoleeva OA; Churakova ZhV
Ter Arkh; 2006; 78(7):46-51. PubMed ID: 16944750
[TBL] [Abstract][Full Text] [Related]
38. Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1,408 cases.
Graff-Baker A; Roman SA; Thomas DC; Udelsman R; Sosa JA
Surgery; 2009 Dec; 146(6):1105-15. PubMed ID: 19958938
[TBL] [Abstract][Full Text] [Related]
39. Diffuse large B-cell lymphoma showing an interfollicular pattern of proliferation: a study of the Osaka Lymphoma Study Group.
Yamauchi A; Ikeda J; Nakamichi I; Kohara M; Fukuhara S; Hino M; Kanakura Y; Ogawa H; Sugiyama H; Kanamaru A; Aozasa K;
Histopathology; 2008 May; 52(6):731-7. PubMed ID: 18397280
[TBL] [Abstract][Full Text] [Related]
40. Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas.
Nyman H; Jerkeman M; Karjalainen-Lindsberg ML; Banham AH; Enblad G; Leppä S
Eur J Haematol; 2009 May; 82(5):364-72. PubMed ID: 19141121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
